RUBIN JONATHAN

PrivateCIK: 1836067
Location

ROCKVILLE, MD

RUBIN JONATHAN (SVP, Chief Medical Officer) sold 10.6% of their position (927.00 shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $36.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderRUBIN JONATHANCIK 1836067
→
Officer· SVP, Chief Medical Officer
Since Jan 2021
-927.00
Net shares
Net seller
$36.3K
Total sold
1
Open market trades
0B · 1S
9
Total transactions
5.13K acquired · 6.05K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+1.88K

Price / share

—

Trade value

—

% of position

27.2%
2/21/2025
6.91K→8.78K

Common Stock

Direct
S · Sale

Shares

−927.00

Price / share

$39.15

Trade value

$36.29K

% of position

10.6%
2/21/2025
8.78K→7.85K

Common Stock

Direct
A · Award

Shares

+750.00

Price / share

—

Trade value

—

% of position

9.6%
2/22/2025
7.85K→8.60K

Common Stock

Direct
A · Award

Shares

+1.25K

Price / share

—

Trade value

—

% of position

14.5%
2/22/2025
8.60K→9.85K

Common Stock

Direct
A · Award

Shares

+1.25K

Price / share

—

Trade value

—

% of position

12.7%
2/23/2025
9.85K→11.10K
Total

Net shares

+4.20K

Net value

-$36.29K

Derivative Transactions4

Performance Share Units

Direct
M · Option Exercise
Converts to

Common Stock

1.88K shares

Shares

−1.88K

Strike price

0

Held after

0.00

Exercisable

—

2/21/2025

Restricted Stock Unit

Direct
D · Disposition
Converts to

Common Stock

750.00 shares

Shares

−750.00

Strike price

Held after

750.00

Exercisable

—

2/22/2025

Restricted Stock Unit

Direct
D · Disposition
Converts to

Common Stock

1.25K shares

Shares

−1.25K

Strike price

Held after

3.75K

Exercisable

—

2/22/2025

Restricted Stock Unit

Direct
D · Disposition
Converts to

Common Stock

1.25K shares

Shares

−1.25K

Strike price

Held after

2.50K

Exercisable

—

2/23/2025
RUBIN JONATHAN — Insider Transaction (Form 4) Filed Feb 24, 2025 | Finecho